tradingkey.logo

Ikena Oncology Inc <IKNA.OQ> expected to post a loss of 19 cents a share - Earnings Preview

ReutersMar 7, 2025 12:35 PM
  • Ikena Oncology Inc IKNA.OQ IKNA.O is expected to show a fall in quarterly revenue when it reports results on May 12 (estimated) for the period ending December 31 2024

  • ​LSEG's mean analyst estimate for Ikena Oncology Inc is for a loss of 19 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Ikena Oncology Inc is $3.00​, above​ its last closing price of $1.43. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.25

-0.27

-0.21

Beat

21.3

Jun. 30 2024

-0.33

-0.35

-0.28

Beat

19.4

Mar. 31 2024

-0.41

-0.41

-0.33

Beat

20​

Dec. 31 2023

-0.43

-0.47

Missed

-9.8

​​Sep. 30 2023

-0.42

-0.43

-0.40

Beat

7

Jun. 30 2023

-0.46

-0.47

-0.44

Beat

7.3​

Mar. 31 2023

-0.47

-0.47

-0.39

Beat

16.6

Dec. 31 2022

-0.53

-0.48

-0.40

Beat

16.1

This summary was machine generated March 7 at 12:35 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI